Resident of Moscow SEZ Khirana+ reports producing 4,000 ventilators
In short
A company resident in the Technopolis Moscow special economic zone has produced 4,000 artificial lung ventilation devices (ventilators), according to RIA Novosti and RBC. RBC identified the company as Khirana+ and said the 4,000 units were made over ten years. The documents give no details on models, buyers or where the devices were supplied.
Why it matters
The reports are production-figure announcements carried by a state news agency and a business outlet, and they concern a single manufacturer of medical equipment. Because the documents give no customer, procurement or export information, they do not establish what the figure means for Russian hospital supply or for the medical device market.
Key facts
- A resident company of the Technopolis Moscow special economic zone has produced 4,000 artificial lung ventilation devices, or ventilators. [ 1 , 2 ]
- RBC named the company as Khirana+. [ 2 ]
- RBC said the 4,000 devices were produced over ten years. [ 2 ]
- RIA Novosti published the figure without naming the company, referring to it only as a resident of the zone. [ 1 ]
- RIA Novosti reported the figure on 4 October 2026 and RBC on 5 October 2026. [ 1 , 2 ]
Confirmed by several sources
Still unclear
- The company's name is given only by RBC, which calls it Khirana+. RIA Novosti's headline refers to the manufacturer only as a resident of the economic zone, so the name rests on a single document.
- What the ventilators were used for, which models were made and who bought them. The documents do not address these points.
- The full text of RBC's report. The summary carried in the documents is truncated mid-sentence and no article text is available.